US 7521192
EDG: modulators of lymphocyte activation and migration
granted A61PA61P37/00
Quick answer
US patent 7521192 (EDG: modulators of lymphocyte activation and migration) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P37/00